In a follow-up analysis to the pivotal TOPAZ-1 study, which established the combination therapy of durvalumab (an ...

Background: The presence of infective microorganisms in the bilio-pancreatic tract is believed to be important in both the onset and outcome of acute biliary pancreatitis. In this study, the ...

IN the clinical landscape of biliary tract infections, accurately predicting which patients are at risk of severe bloodstream infections (BSIs) can be lifesaving. A new study offers compelling ...

Biliary tract infections (BTI), often linked to structural abnormalities like bile duct stones, pose significant treatment challenges due to drug-resistant bacteria like Pseudomonas aeruginosa ...

Treatment with tovecimig, formerly known as CTX-009, elicited responses in patients with biliary tract cancer, according to COMPANION-002 study results.

Topline data were announced from a phase 2/3 trial evaluating tovecimig plus paclitaxel in patients with advanced biliary tract cancer.

Gallbladder cancer, a highly aggressive disease, often goes undiagnosed until advanced stages due to nonspecific symptoms and lack of routine screening. Risk factors include chronic inflammation, ...

An expert explains what biliary tract cancers are and the current landscape of treatment as well as future advancements.

The study was the first Phase III clinical trial conducted entirely in the United States for newly diagnosed, advanced biliary tract cancer patients.

Medically reviewed by Jay N. Yepuri, MD Primary biliary cholangitis (PBC), also known as primary biliary cirrhosis, is a chronic and progressive disease that damages and can eventually destroy the ...